MedPlus Health Services reported a strong performance in Q3 FY26, with net profit after tax reaching ₹577.88 million, up from ₹458.70 million in the same quarter last year. The board also approved the allotment of 2,32,061 equity shares under the Employee Stock Option Plan (ESOP) 2021. Unaudited standalone and consolidated financial results were approved during the board meeting held on January 30, 2026.
Financial Performance
MedPlus Health Services reported its unaudited consolidated financial results for the quarter ended December 31, 2025 (Q3 FY26). Key highlights include:
- Total Income: ₹18,243.59 million
- Net Profit After Tax: ₹577.88 million compared to ₹458.70 million for the same quarter last year.
- Earnings per share: Basic EPS of ₹4.82 and Diluted EPS of ₹4.81
The standalone financial results show a Net Profit After Tax of ₹165.76 million for Q3 FY26. Revenue from operations was ₹2,230.01 million.
ESOP Allotment
The board of directors approved the allotment of 2,32,061 Equity Shares under the MedPlus Employees Stock Option Plan, 2021 (‘ESOP,2021’) to eligible employees of the Company/ Group Company. Detailed disclosures regarding the ESOP allotment will be provided separately.
Segment Performance
Segment revenue for the quarter ended December 31, 2025:
- Retail: ₹17,733.70 million
- Diagnostic Services: ₹326.67 million
Source: BSE
